AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Carvitop 6.25mg Tablet IR

Prescription Icon
Prescription Required

Marketer

Docheal Pharma Pvt Ltd

Salt Composition

Carvedilol (6.25mg)

Overview Carvitop 6.25mg Tablet IR

Cardiotop 6.25mg Immediate-Release tablets treat hypertension, angina pectoris, and congestive heart failure. Its mechanism involves vasodilation, improving blood flow to the heart. This, in turn, reduces the risk of myocardial infarction and cerebrovascular accident. Cardiotop 6.25mg IR should be ingested with food, following your physician's prescribed dosage and regimen. Consistent use is crucial, even with symptom improvement or blood pressure normalization. Discontinuation requires medical consultation to avoid potential complications. Lifestyle modifications, such as regular physical activity, weight management, smoking cessation, moderate alcohol consumption, and a low-sodium diet (as directed by your doctor), enhance treatment efficacy. While generally well-tolerated, potential side effects include lightheadedness, cephalalgia, dyspnea, and fatigue. Report persistent or bothersome adverse effects to your doctor. Prior to commencing treatment, inform your physician of any pre-existing cardiac or renal conditions. Pregnant or lactating individuals should seek medical advice before initiating therapy.

Primary Ingredients of Carvitop 6.25mg Tablet IR

No text provided. Please provide the text you wish me to rephrase.

Uses of Carvitop 6.25mg Tablet IR

Managing elevated blood pressure | Alleviating angina pectoris | Treating congestive heart failure

Major Benefits of Carvitop 6.25mg Tablet IR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Carvitop 6.25mg Immediate-Release Tablet with a meal.

Common Side effects of Carvitop 6.25mg Tablet IR:

  • Decreased blood pressure
  • Headache
  • Fatigue
  • Dizziness
  • Breathlessness

How to use Carvitop 6.25mg Tablet IR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Carvitop 6.25mg Tablet IR whole; do not crush, chew, or divide it. Administer this medication with food.

How Carvitop 6.25mg Tablet IR works:

Carvitop 6.25mg Immediate-Release tablets combine alpha and beta-blocking properties. This dual action reduces heart rate and dilates blood vessels, thereby improving the heart's pumping efficiency.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Carvitop 6.25mg Tablet IR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Carvitop 6.25mg Immediate-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Physician consultation is advised.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and the use of 6.25mg immediate-release Carvitop tablets appear compatible. Available human data indicates minimal infant risk associated with this medication.

DrivingDrivingUNSAFE

Taking Carvitop 6.25mg immediate-release tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Carvitop 6.25mg immediate-release tablets may be used by patients with kidney disease without dosage modification. Nevertheless, disclosure of any pre-existing renal impairment to your physician is advisable. Routine blood pressure checks are suggested to guide any necessary dose alterations.

LiverLiverCAUTION

Exercise caution when administering Carvitop 6.25mg immediate-release tablets to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Carvitop 6.25mg immediate-release tablets are contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Carvitop 6.25mg Tablet IR :

Should you forget a Carvitop 6.25mg Tablet IR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Carvitop 6.25mg Tablet IR

LabelValue
Chemical Category Carbazole-propanol derivative
Developing Habits No.
Type of Therapy Heart
Action Class Alpha-beta blocker

FAQs on Carvitop 6.25mg Tablet IR

Take Carvitop 6.25mg Tablets regularly as prescribed. Abruptly stopping this medication can lead to chest pain or a heart attack. Your doctor will gradually reduce your dose before discontinuation, if necessary.
Carvitop 6.25mg Tablets can cause drowsiness and dizziness, particularly at the start of treatment or after a dose increase. Avoid driving or operating machinery if affected.
Weight gain is a possible side effect of Carvitop 6.25mg Tablet IR, though not universal. If you're using it for heart failure and experience weight gain or shortness of breath, inform your doctor immediately; these could indicate fluid retention.
In heart failure patients, Carvitop 6.25mg Tablet IR may rarely worsen kidney function. This risk is increased in patients with low blood pressure (systolic <100 mmHg), hardened arteries, pre-existing heart disease, or impaired kidney function. Close monitoring is advised for these patients. Kidney function typically recovers after discontinuing Carvitop 6.25mg Tablet IR.
Diabetic patients may take Carvitop 6.25mg Tablet IR, but require regular blood glucose monitoring. Studies show minimal impact on blood glucose in well-controlled diabetics with mild to moderate hypertension. However, beta-blockers like Carvitop can mask hypoglycemic symptoms, such as increased heart rate. Furthermore, Carvitop may worsen hyperglycemia in diabetic patients with heart failure. Therefore, close blood glucose monitoring is crucial when starting, adjusting, or stopping Carvitop, and any changes should be reported to a physician.
Taking Carvitop 6.25mg Tablet IR with food slows absorption and helps prevent dizziness or fainting from low blood pressure upon standing (orthostatic hypotension).
Carvitop 6.25mg Tablets can cause serious side effects including fainting, shortness of breath, weight gain, and swelling in the extremities (arms, hands, feet, ankles, or lower legs). Other possible side effects are chest pain, abnormal heartbeat, rash, hives, itching, and difficulty breathing or swallowing. Seek immediate medical attention if any of these occur.
Taking more Carvitop 6.25mg Tablet IR than prescribed can cause slow heart rate, dizziness, fainting, breathing problems, vomiting, unconsciousness, or seizures. Seek immediate medical attention at a hospital and contact your doctor.
Carvitop 6.25mg Tablet IR is contraindicated in patients with severe heart failure requiring ICU admission or inotropic support, those with asthma or other respiratory issues, bradycardia or arrhythmias, hepatic impairment, or a known allergy to Carvitop 6.25mg Tablet IR.
Carvitop 6.25mg Tablet IR
37
MRP 45
17% off